Spots Global Cancer Trial Database for bone sarcoma
Every month we try and update this database with for bone sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI | NCT01336803 | Bone Cancer Chondrosarcoma Ewing's Sarcoma Osteosarcoma Rhabdomyosarcom... Bone Necrosis Bone Sarcoma Osteomyelitis | Feraheme Magnetic Resona... | 10 Years - 21 Years | Stanford University | |
| Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma | NCT02384473 | Adult Soft Tiss... Bone Sarcoma Retroperitoneal... | Real-Time CEUS SWE Definity Suspen... Philips Shear W... | 18 Years - | University of Southern California | |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease | NCT01588522 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer Primary Periton... Bone Sarcoma Cancer Solid Tumor | compound 31543 ... | 18 Years - | Berg, LLC | |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | NCT03449108 | Bone Sarcoma Dedifferentiate... Giant Cell Tumo... Malignancy in G... Malignant Solid... Ovarian Carcino... Platinum-Resist... Poorly Differen... Recurrent Osteo... Recurrent Ovari... Refractory Oste... Soft Tissue Sar... Thyroid Gland A... Thyroid Gland S... Undifferentiate... Triple Negative... | Aldesleukin Autologous Tumo... Autologous Tumo... Cyclophosphamid... Fludarabine Ipilimumab Nivolumab Quality-of-Life... Questionnaire A... | 16 Years - 70 Years | M.D. Anderson Cancer Center | |
| Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients | NCT05051059 | Soft Tissue Sar... Bone Sarcoma | Functional outc... Health related ... | 18 Years - 95 Years | Universitaire Ziekenhuizen KU Leuven | |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease | NCT01588522 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer Primary Periton... Bone Sarcoma Cancer Solid Tumor | compound 31543 ... | 18 Years - | Berg, LLC | |
| Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma | NCT04515459 | Sarcoma | Surgical prehab... | 16 Years - | Institut Claudius Regaud | |
| Dalteparin in Preventing DVT in Participants With Cancer | NCT00525057 | Bone Sarcoma Femur Fracture Lymphoma Metastatic Neop... Pathologic Frac... Plasma Cell Mye... Soft Tissue Sar... | Dalteparin | 30 Years - | M.D. Anderson Cancer Center | |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | NCT04698785 | Bone Sarcoma Osteosarcoma | Treatment by re... Treatment by pl... | 12 Years - | Centre Leon Berard | |
| Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma | NCT06129903 | Sarcoma Bone Sarcoma Soft Tissue Sar... | referral to the... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK | NCT04181970 | Soft-tissue Sar... Gastrointestina... Bone Sarcoma | Quality assessm... | 18 Years - 120 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas | NCT00592293 | Non-rhabdomyosa... Bone Sarcoma | Proton Beam Rad... | - 30 Years | Massachusetts General Hospital | |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease | NCT01588522 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer Primary Periton... Bone Sarcoma Cancer Solid Tumor | compound 31543 ... | 18 Years - | Berg, LLC | |
| Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance | NCT06202599 | Bone Sarcoma Soft Tissue Sar... Refractory Tumo... | Fruquintinib | - | Peking University People's Hospital | |
| Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Bone Sarcoma | NCT05746429 | Bone Sarcoma | Cognitive Behav... Transcranial Di... Interview Placebo Adminis... Questionnaire A... | 10 Years - | St. Jude Children's Research Hospital | |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas | NCT04906876 | Sarcoma Soft Tissue Sar... Metastatic Sarc... Undifferentiate... Myxofibrosarcom... Leiomyosarcoma Liposarcoma Angiosarcoma Synovial Sarcom... Rhabdomyosarcom... Spindle Cell Sa... High Grade Sarc... Bone Sarcoma | Gemcitabine Docetaxel 9-ING-41 | 10 Years - | Brown University | |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma | NCT01803152 | Sarcoma Soft Tissue Sar... Bone Sarcoma | Dendritic Cells... Lysate of Tumor Gemcitabine Imiquimod Leukapheresis | 1 Year - 100 Years | University of Miami | |
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma | NCT05116800 | Soft Tissue Sar... Undifferentiate... Myxofibrosarcom... Leiomyosarcoma Liposarcoma Angiosarcoma Synovial Sarcom... Rhabdomyosarcom... Spindle Cell Sa... High Grade Sarc... Bone Sarcoma Osteosarcoma Ewing Sarcoma o... | Gemcitabine 9-ING-41 Docetaxel | 10 Years - | Brown University | |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | NCT01491594 | Sarcoma, Soft T... Osteosarcoma Neoplasms, Conn... | Eltrombopag | 18 Years - 82 Years | Duke University | |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | NCT04698785 | Bone Sarcoma Osteosarcoma | Treatment by re... Treatment by pl... | 12 Years - | Centre Leon Berard | |
| Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma | NCT06409013 | Bone Sarcoma Soft Tissue Sar... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas | NCT02301039 | Soft Tissue Sar... Bone Sarcoma | Pembrolizumab | 12 Years - | Sarcoma Alliance for Research through Collaboration | |
| Gemcitabine With Ascorbate Including Adolescents | NCT04877587 | Soft Tissue Sar... Bone Sarcoma Unresectable So... Metastatic Bone... Metastatic Soft... Unresectable Bo... | Ascorbate Gemcitabine | 13 Years - 17 Years | University of Iowa | |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma | NCT02520128 | Soft Tissue Sar... Ewing Sarcoma Bone Sarcoma Chordoma | Intensity modul... | 16 Years - | University College, London | |
| Dalteparin in Preventing DVT in Participants With Cancer | NCT00525057 | Bone Sarcoma Femur Fracture Lymphoma Metastatic Neop... Pathologic Frac... Plasma Cell Mye... Soft Tissue Sar... | Dalteparin | 30 Years - | M.D. Anderson Cancer Center | |
| Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma | NCT04735289 | Osteosarcoma Ewing Sarcoma | EPIC-COS Food F... Metabolome, Mic... | 12 Years - | Istituto Ortopedico Rizzoli | |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas | NCT03442465 | Bone Sarcoma Osteosarcoma Chondrosarcoma Ewing's Sarcoma Osseous Sarcoma Bone Neoplasm | Toronto Extremi... Musculoskeletal... Timed Get Up an... Orthogonal Radi... Weight Bearing ... Range of Motion | 4 Years - | Memorial Sloan Kettering Cancer Center | |
| Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas | NCT00592293 | Non-rhabdomyosa... Bone Sarcoma | Proton Beam Rad... | - 30 Years | Massachusetts General Hospital | |
| In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors | NCT04616248 | Anatomic Stage ... Metastatic Brea... Prognostic Stag... Unresectable Br... Metastatic Mela... Unresectable Me... Cutaneous Squam... Merkel Cell Car... Soft Tissue Sar... Bone Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone | Anti-CD40 Agoni... Poly ICLC Radiation Thera... Recombinant Flt... | 18 Years - | University of Southern California | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) | NCT04634227 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate | 18 Years - | University of Iowa | |
| A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma | NCT01896505 | Sarcoma | KCP-330 | 18 Years - | Karyopharm Therapeutics Inc | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors | NCT05057130 | Osteosarcoma Neoplasms, Conn... Neoplasms, Conn... Sarcoma Sarcoma of Bone | Doxorubicin, Ci... Doxorubicin, Ci... | 24 Years - 40 Years | Blokhin's Russian Cancer Research Center | |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | NCT01491594 | Sarcoma, Soft T... Osteosarcoma Neoplasms, Conn... | Eltrombopag | 18 Years - 82 Years | Duke University | |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK | NCT04181970 | Soft-tissue Sar... Gastrointestina... Bone Sarcoma | Quality assessm... | 18 Years - 120 Years | Grupo Espanol de Investigacion en Sarcomas | |
| SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas | NCT02301039 | Soft Tissue Sar... Bone Sarcoma | Pembrolizumab | 12 Years - | Sarcoma Alliance for Research through Collaboration | |
| Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma | NCT04735289 | Osteosarcoma Ewing Sarcoma | EPIC-COS Food F... Metabolome, Mic... | 12 Years - | Istituto Ortopedico Rizzoli | |
| A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma | NCT05621668 | Soft Tissue Sar... Bone Sarcoma | Cyclophosphamid... attIL2-T cells | 12 Years - | M.D. Anderson Cancer Center | |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | NCT05033288 | Bone Sarcoma Chondrosarcoma Chordoma Ewing Sarcoma o... Pelvic Rhabdomy... | Electronic Heal... Quality-of-Life... | 15 Years - | Mayo Clinic | |
| Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Bone Sarcoma | NCT05746429 | Bone Sarcoma | Cognitive Behav... Transcranial Di... Interview Placebo Adminis... Questionnaire A... | 10 Years - | St. Jude Children's Research Hospital | |
| Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas | NCT05515068 | Osteosarcoma Bone Tumor Bone Sarcoma High Grade Sarc... Osteoblastic Os... Chondroblastic ... Fibroblastic Os... Conventional Os... Conventional Ce... Low Grade Centr... Osseous Sarcoma Osseous Tumor Small Cell Oste... Telangiectatic ... Undifferentiate... Parosteal Osteo... Periosteal Oste... Extraskeletal O... Recurrent Osteo... High Grade Surf... Osseous Angiosa... Osseous Fibrosa... Osseous Leiomyo... Osseous Dediffe... Osseous Mesench... Clear Cell Oste... | - | Klinikum Stuttgart | ||
| Gemcitabine Plus Ascorbate for Sarcoma in Adults | NCT03468075 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate Gemcitabine | 18 Years - | University of Iowa | |
| In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma | NCT02811523 | Bone Sarcoma Soft Tissue Sar... Pulmonary Metas... | Doxorubicin | 0 Years - 64 Years | University Health Network, Toronto | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults | NCT03468075 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate Gemcitabine | 18 Years - | University of Iowa | |
| Exercise Intervention for Bone Tumor Patients | NCT04963517 | Bone Sarcoma | Exercise therap... Information | 15 Years - 45 Years | Universität Duisburg-Essen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
